The profound vascular rearrangement characterizing GB involves a variety of cellular and biological processes, including the existence of tumor CD133+ multipotent cells capable of endothelial lineage differentiation [64] and the repeatedly documented dysregulation of pro-angiogenic and anti-angiogenic pathways. This evidence concerns the gene PROM1 and neoplasm.